Live tape
Top 8, mentions 7d19,874GOOGL8,320 mentions▲ +0.02MSFT2,075 mentions▲ +0.04AMZN1,920 mentions▲ +0.04INTC1,851 mentions▲ +0.03META1,493 mentions▲ +0.03NVDA1,473 mentions▲ +0.06RDDT1,433 mentions▲ +0.04TSLA1,309 mentions▲ +0.05

Equity · Healthcare

BLFS

NASDAQ

BioLife Solutions (BLFS)

38.58 USD +3.50% vs prior close Oct 5, 2026
BioLife Solutions, Inc. price graph
45 sessions
40.0 30.0 3 Aug 5 Oct

The line runs 32 USD on 3 August through 38.58 USD on 5 October, on a scale from 30.0 to 40.0. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView
Market cap
1.9B USD
P/E (TTM)
33.3
Revenue, year to Dec 2025
96.2M USD
EPS, diluted, year to Dec 2025
−0.10 USD
52-week range
18.15 USD – 39 USD
Avg volume
59.4K

as of Oct 5, 2026

Have BioLife Solutions (BLFS) insiders bought or sold shares recently?

In the 90 days to 1 Nov 2026, no BioLife Solutions insider bought or sold shares on the open market; all 29 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).

Form 4, 90 days to 1 Nov 2026, newest Form 4 filing 6 Oct 2026

Buys 0Sells 0Other filings 29

Have BioLife Solutions (BLFS) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
06 Oct 2026Wichterman TroyChief Financial OfficerAward138,504
06 Oct 2026Wichterman TroyChief Financial OfficerTax withheld95,9333.7M USD
06 Oct 2026Wichterman TroyChief Financial OfficerOther256,000
06 Oct 2026GOSWAMI JOYDEEPDirectorOther53,156
06 Oct 2026Ellingson RachelDirectorOther57,995
06 Oct 2026DuRoss AmyDirectorOther26,857
06 Oct 2026Coste CatherineDirectorOther13,871
06 Oct 2026DE GREEF RODERICKChief Executive OfficerAward463,130
06 Oct 2026DE GREEF RODERICKChief Executive OfficerTax withheld364,87214.1M USD
06 Oct 2026DE GREEF RODERICKChief Executive OfficerOther826,454
06 Oct 2026Hunt AnthonyDirectorOther15,046
06 Oct 2026MOORE TIMOTHY L.DirectorOther44,943

Showing the 12 most recent of 29 compensation filings in this window. The figures above count all of them.

Which funds hold BioLife Solutions (BLFS)?

7 of the 45 institutional funds we track reported a BioLife Solutions position for the quarter ended 30 Jun 2026 — a combined 28.7M USD; the latest of those filings landed 02 Sep 2026.

Form 13F

Which funds hold BioLife Solutions (BLFS)?
FundPositionSharesValueShares q/q
Millennium ManagementNew position625,65817.7M USD
Citadel AdvisorsTrimmed157,9444.5M USD−35.3%
Man GroupAdded145,5034.1M USD+100.3%
Point72 Asset ManagementNew position35,019989K USD
Marshall WaceNew position23,692669K USD
AQR Capital ManagementNew position15,739444K USD
D. E. Shaw & Co.Trimmed12,349349K USD−87.9%
Renaissance TechnologiesExited

Have members of Congress traded BioLife Solutions (BLFS)?

The most recent congressional trade disclosed in BioLife Solutions is a sale by Sara Jacobs (house, CA), dated 12 Dec 2022.

STOCK Act disclosures

Have members of Congress traded BioLife Solutions (BLFS)?
TradedMemberTypeAmountFiled after
12 Dec 2022Sara Jacobshouse · Democrat–CASale1K USD–15K USD39 days

What has been filed or recorded for BioLife Solutions (BLFS)?

The filings we hold for BioLife Solutions, newest first: 2 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 07 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for BioLife Solutions (BLFS)?
And
07 Oct 2026Fails to deliverShares failed to deliver119 shares5K USD notional · <0.001% of shares out
21 Sep 2026Fails to deliverShares failed to deliver4,431 shares163K USD notional · 0.009% of shares out
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS 0.91 USD
30 Jun 2026FinancialsTotal assets447.5M USDat period end
30 Jun 2026FinancialsTotal equity420.0M USDat period end
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS 0.02 USD
31 Dec 2025Annual reportFY 2025 reportedEPS −0.10 USD
31 Dec 2025FinancialsRevenue96.2M USDfiscal year
31 Dec 2025FinancialsNet income−4.6M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−0.10 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS 0.01 USD
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −0.33 USD
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS 0.00 USD
31 Dec 2024Annual reportFY 2024 reportedEPS −0.44 USD
30 Sep 2024Quarterly earningsQ3 2024 reportedEPS −0.04 USD

BioLife Solutions (BLFS): frequently asked questions

From live data
38.58

What did BioLife Solutions shares close at?

BioLife Solutions closed at 38.58 USD on 5 Oct 2026, up 3.50% on the close before. That is the end-of-day price from Finazon, not a live quote.

1.9B

What is BioLife Solutions’ market cap?

BioLife Solutions is worth 1.9B USD by market value as of 5 Oct 2026, which is the share price times the shares on issue from its SEC filings.

33.3

What is BioLife Solutions’ P/E ratio?

BioLife Solutions has a price-to-earnings ratio of 33.3, as of 5 Oct 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.

96.2M

What is BioLife Solutions’ revenue?

BioLife Solutions reported revenue of 96.2M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

29 filings

Have BioLife Solutions insiders bought or sold shares recently?

In the 90 days to 1 Nov 2026, no BioLife Solutions insider bought or sold shares on the open market; all 29 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4). See Insiders

7 of 45

Which funds own BioLife Solutions?

7 of the 45 funds we track reported a BioLife Solutions position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Millennium Management, Citadel Advisors and Man Group. See Funds

1 trade

Have members of Congress traded BioLife Solutions?

Yes. 1 trade in BioLife Solutions appears in the congressional disclosures we hold: a sale by Sara Jacobs (House, CA) dated 12 Dec 2022, filed 20 Jan 2023. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress

0.91

When did BioLife Solutions last report earnings?

BioLife Solutions last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of 0.91 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. House disclosuresU.S. House of Representatives financial disclosures
  6. SECSEC fails-to-deliver (CNS) data
  7. SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
  8. SEC EDGARreported earnings figures and scheduled report dates
  9. SEC EDGARValuation computed from SEC EDGAR filings